217 related articles for article (PubMed ID: 12714522)
41. B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation.
Zan H; Li Z; Yamaji K; Dramitinos P; Cerutti A; Casali P
J Immunol; 2000 Jul; 165(2):830-9. PubMed ID: 10878357
[TBL] [Abstract][Full Text] [Related]
42. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.
Pasqualucci L; Migliazza A; Basso K; Houldsworth J; Chaganti RS; Dalla-Favera R
Blood; 2003 Apr; 101(8):2914-23. PubMed ID: 12515714
[TBL] [Abstract][Full Text] [Related]
43. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma.
Gutiérrez MI; Bhatia K; Cherney B; Capello D; Gaidano G; Magrath I
Ann Oncol; 1997 Oct; 8(10):987-94. PubMed ID: 9402172
[TBL] [Abstract][Full Text] [Related]
44. Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type.
Seitz V; Hummel M; Anagnostopoulos I; Stein H
Blood; 2001 Apr; 97(8):2401-5. PubMed ID: 11290603
[TBL] [Abstract][Full Text] [Related]
45. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
[TBL] [Abstract][Full Text] [Related]
46. Deletion of murine
Horiguchi H; Xu H; Duvert B; Ciuculescu F; Yao Q; Sinha A; McGuinness M; Harris C; Brendel C; Troeger A; Chiarle R; Williams DA
Small GTPases; 2022 Jan; 13(1):267-281. PubMed ID: 34983288
[TBL] [Abstract][Full Text] [Related]
47. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
Tanaka S; Louie DC; Kant JA; Reed JC
Blood; 1992 Jan; 79(1):229-37. PubMed ID: 1339299
[TBL] [Abstract][Full Text] [Related]
48. BCL-6 mutations in pulmonary lymphoproliferative disorders: demonstration of an aberrant immunological reaction in HIV-related lymphoid interstitial pneumonia.
Kurosu K; Weiden MD; Takiguchi Y; Rom WN; Yumoto N; Jaishree J; Nakata K; Kasahara Y; Tanabe N; Tatsumi K; Mikata A; Kuriyama T
J Immunol; 2004 Jun; 172(11):7116-22. PubMed ID: 15153535
[TBL] [Abstract][Full Text] [Related]
49. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
Butler M; Corbally N; Dervan PA; Carney DN
Br J Cancer; 1997; 75(11):1641-5. PubMed ID: 9184180
[TBL] [Abstract][Full Text] [Related]
50. Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas.
Bhatia K; Spangler G; Gaidano G; Hamdy N; Dalla-Favera R; Magrath I
Blood; 1994 Aug; 84(3):883-8. PubMed ID: 8043869
[TBL] [Abstract][Full Text] [Related]
51. AIDS-related B-cell non-Hodgkin's lymphomas in direct blood-stream HIV-infected patients: pathogenesis and differentiation features.
Boiocchi M; Carbone A; De Re V; Dolcetti R; Volpe R; Tirelli U
Int J Cancer; 1990 May; 45(5):883-8. PubMed ID: 2159439
[TBL] [Abstract][Full Text] [Related]
52. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.
Dijkman R; Tensen CP; Buettner M; Niedobitek G; Willemze R; Vermeer MH
Blood; 2006 Jun; 107(12):4926-9. PubMed ID: 16507780
[TBL] [Abstract][Full Text] [Related]
53. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression.
Carbone A; Gaidano G; Gloghini A; Pastore C; Saglio G; Tirelli U; Dalla-Favera R; Falini B
Am J Pathol; 1997 Jan; 150(1):155-65. PubMed ID: 9006332
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology and pathogenesis of AIDS-related lymphomas.
Aboulafia D
Oncology (Williston Park); 1998 Jul; 12(7):1068-81; discussion 1081 passim. PubMed ID: 9684278
[TBL] [Abstract][Full Text] [Related]
55. Common-variable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: pathogenetic and histogenetic implications.
Ariatti C; Vivenza D; Capello D; Migliazza A; Parvis G; Fassone L; Buonaiuto D; Savinelli F; Rossi D; Saglio G; Gaidano G
Hum Pathol; 2000 Jul; 31(7):871-3. PubMed ID: 10923927
[TBL] [Abstract][Full Text] [Related]
56. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
Clark HM; Yano T; Otsuki T; Jaffe ES; Shibata D; Raffeld M
Cancer Res; 1994 Jul; 54(13):3383-6. PubMed ID: 8012955
[TBL] [Abstract][Full Text] [Related]
57. Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.
Traverse-Glehen A; Verney A; Baseggio L; Felman P; Callet-Bauchu E; Thieblemont C; Ffrench M; Magaud JP; Coiffier B; Berger F; Salles G
Leukemia; 2007 Aug; 21(8):1821-4. PubMed ID: 17476282
[No Abstract] [Full Text] [Related]
58. AIDS primary central nervous system lymphoma: molecular analysis of the expressed VH genes and possible implications for lymphomagenesis.
Julien S; Radosavljevic M; Labouret N; Camilleri-Broet S; Davi F; Raphael M; Martin T; Pasquali JL
J Immunol; 1999 Feb; 162(3):1551-8. PubMed ID: 9973412
[TBL] [Abstract][Full Text] [Related]
59. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
[TBL] [Abstract][Full Text] [Related]
60. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
